Sumitomo Dainippon Pharma Co Ltd - Interest Expense

Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Interest-Expense" stands at 55.30 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the highest value at least since 12/31/2011, the period currently displayed.

Sumitomo Dainippon Pharma Co Ltd's first quarter result of 9.05 Billion JPY for the item "Interest Expense" represents an increase of 21.50 percent compared to it's fourth quarter result of the company's last fiscal year.

Also, Sumitomo Dainippon Pharma Co Ltd's first quarter result of 9.05 Billion JPY for the item "Interest Expense" represents an increase of 347.06 percent compared to it's first quarter result of last year.

Looking again at the trailing twelve months series (TTM), Sumitomo Dainippon Pharma Co Ltd's first quarter result of 55.30 Billion JPY for the item "Interest Expense" represents an increase of 14.56 percent compared to it's fourth quarter result of the company's last fiscal year.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 148.72 percent compared to the value the year prior.
The 1 year change in percent is 148.72.
The 3 year change in percent is 1,760.23.
The 5 year change in percent is 502.58.
The 10 year change in percent is 5,796.03.

The Serie's long term average value is 10.02 Billion Japanese Yens. It's latest available value, on 06/30/2025, is 451.92 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2017, to it's latest available value, on 06/30/2025, is +13,067.80%.
The Serie's change in percent from it's maximum value, on 06/30/2025, to it's latest available value, on 06/30/2025, is 0.0%.